These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16398384)

  • 21. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired long QT interval complicated with Torsades de Pointes as presentation of a pheochromocytoma in a paediatric patient: a case report.
    Cecilia GM; Emilien D; Laurent H
    Cardiol Young; 2015 Feb; 25(2):391-3. PubMed ID: 24694650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Torsades de pointes complicating complete heart block with QT interval prolongation.
    Stankovic I; Putnikovic B; Neskovic AN
    Acta Cardiol; 2016; 71(5):627. PubMed ID: 27695027
    [No Abstract]   [Full Text] [Related]  

  • 24. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long QT syndrome and torsades de pointes complicating mitral valve replacement.
    Gilbert S; Singh D; Jesuraj ML
    Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S210-S211. PubMed ID: 27751291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An unusual cause of giddiness. Fig. 1: Complete heart block with prolonged QT interval. Fig. 2: Torsades de pointes.
    Ng KS; Choo MH
    Singapore Med J; 1993 Feb; 34(1):81-2, 92. PubMed ID: 8266138
    [No Abstract]   [Full Text] [Related]  

  • 30. Quasi-experimental study to improve nurses' QT-interval monitoring: results of QTIP study.
    Pickham D; Shinn JA; Chan GK; Funk M; Drew BJ
    Am J Crit Care; 2012 May; 21(3):195-200; quiz 201. PubMed ID: 22549576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
    Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH
    Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Psychiatric patients and QT interval monitoring].
    Girardin F; Gaspoz JM
    Rev Med Suisse; 2007 Apr; 3(106):945-8. PubMed ID: 17575970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol].
    Guy JM; André-Fouet X; Porte J; Bertrand M; Lamaud M; Verneyre H
    Ann Cardiol Angeiol (Paris); 1991 Nov; 40(9):541-5. PubMed ID: 1776799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation and Management of Athletes With Long QT Syndrome.
    Gomez AT; Prutkin JM; Rao AL
    Sports Health; 2016; 8(6):527-535. PubMed ID: 27480102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired long QT syndrome: long-term electrocardiographic (Holter) recording of torsades de pointes ending in asystole: II.
    Raviña T; Gutierrez J; Raviña P
    Int J Cardiol; 2007 Mar; 116(2):272-5. PubMed ID: 16859777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method for constructing and estimating the RR-memory of the QT-interval and its inclusion in a multivariate biomarker for torsades de pointes risk.
    Trost DC
    J Biopharm Stat; 2008; 18(4):773-96. PubMed ID: 18607807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.